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In recent years a great deal of evidence6 has accumulated which
indicates a close relation between the liberation of histamine and
various allergic and anaphylactic reactions. We have therefore been
employing histamine as a non-specific "desensitizing" agent in most
of our allergic patients during the past few years. Our results with
this form of th,erapy are discussed elsewhere.7 8
In a series of investigations, Code' 2, 3 '4'5 has shown that the
principal source of the histamine in the blood stream is probably
the circulating eosinophils. It is well known that most allergic
patients show an eosinophilia,9 although this is not constant and does
not appear to be related in any obvious manner with the severity
of the symptoms. The relationship between eosinophils and allergic
diseases is not clear. As Peshkin and Messer"' have stated:
"Eosinophilia is met with in a variety of conditions, but it is gen-
erally agreed that the eosinophil is in some way bound up with the
allergic syndrome."
In view of the apparent interrelation between allergic diseases,
the release of histamine, and the circulating eosinophils, it was
decided to investigate the effect of a course of histamine injections
on the percentage of the eosinophils in the blood of a group of
allergic patients. A review of the literature shows that many sub-
stances, injected into man and animals, have produced an eosino-
philia. An extensive bibliography of this subject is given by Peshkin
and Messer,1 who summarize their work and that of others as
follows: "Eosinophilia in animals has been brought about experi-
mentally by the injection of a variety of protein substances. More-
over, it has been shown that eosinophilia follows repeated injections
of large doses of an antigenic substance-specific or non-specific.
The response of the eosinophil cells to various antigenic substances
in the animal is in marked contrast to the lack of uniformity of
response in man. The stimulating influence of antigenic substances
on the eosinophil cells in man seems to be bound up with the par-
ticular antigen employed rather than the dose or the number of
injections administered."
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The effect of histamine injections on the white blood cells of
man and animals has been reported by a few investigators. This
work has been summarized by Moon, Lieber, and Kennedy."0 All
the experiments consisted of noting the variations in the white blood
cell count after a single injection of histamine. Although the vari-
ous investigators disagree concerning the exact changes, all are in
essential agreement that the counts almost always return to approxi-
mately the initial level within 24 hours. It is probable that the
fluctuations depend on temporary vascular changes with redistribu-
tion of the white cells. A problem which seems of considerably
more theoretical interest in the study of allergic diseases is what
changes, if any, occur in the level of circulating eosinophils as a
result of a long series of injections of histamine.
Experimental
The patients included in this study were all hay-fever sufferers.
A few of them also had asthma or vasomotor rhinitis, but the large
majority had no clinical manifestations of allergy other than pol-
lenosis. They were all being given pre-seasonal treatment with
gradually increasing doses of histamine phosphate(1.0cc.- 1.0mg.)
subcutaneously at intervals of from 2 to 7 days. The initial injec-
tion was in most instances 1.0 gamma, although it varied from 0.05
to 1.0 gamma. The increase in dosage in subsequent injections was
approximately 50 to 100 per cent, with a maximum dosage of from
120 to 200 gamma in the majority of patients. The number of
injections and the total dose for each patient are shown in the table.
Treatment was over an average period of 11.5 weeks. Only those
patients, 22 in number, who came regularly and who received an
adequate amount of histamine are included in this study.
Blood smears were taken from each individual just before the
first injection and again two to four days after an injection given
shortly before the onset of the hay-fever season. Thus, the count
was not influenced in any case by the presence of hay-fever. The
smears were stained with MacNeal's tetrachrome stain, which was
left on the slide for 2 to 3 minutes, followed by tap-water for only
30 to 45 seconds in order to bring out the eosinophilic granules as
distinctly as possible. It was thus easy not to confuse eosinophils
and neutrophils, an errorwhich occasionally occurs with poorly made
stains and when the water is left on for more than 45 seconds. A
differential count of 300 white cells was done by moving the
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mechanical stage in zig-zag fashion from one edge of the slide to
the other across the narrower dimension. In this way the edges,
where disproportionately large numbers of polymorphonuclear
leukocytes sometimes gather, were examined as well as the central
portion.
EOSINOPHIL PERCENTAGE BEFORE AND AFTER HISTAMINE INJECTIONS
Before
Case %o
1 4.0
2 3.0
3 3.7
4 1.3
5 3.3
6 2.3
7 9.7
8 11.7
9 3.3
10 3.3
11 4.7
12 6.0
13 1.0
14 3.3
15 3.3
16 0.7
17 1.7
18 1.7
19 1.0
20 3.3
21 1.0
22 2.3
3.44
After
1.7
5.3
3.3
1.3
2.3
4.7
14.0
10.0
5.0
3.0
3.3
6.7
2.3
0.3
4.0
1.7
2.3
2.7
1.3
4.0
1.0
1.3
3.70
Ifitial
dose
1.)
1.0
1.0
1.0
1.0
1.0
0.50
0.05
0.10
0.10
0.10
0.20
0.10
0.10
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
0.70
Date
1940
5/20
6/3
6/3
6/3
6/3
6/10
5/8
4/24
4/29
4/22
3/18
4/17
6/5
6/5
6/5
6/5
6/10
6/12
6/12
6/12
6/7
6/24
Highest Totd
dose Date No. of dose
(y) 1940 inj. (y)
190 8/5 14 976
200 8/5 16 1315
200 8/7 14 1165
150 8/5 22 733
150 8/2 16 843
100 8/9 14 327
50 8/12 31 313
25 8/14 26 262
130 8/2 16 563
140 8/5 28 1068
140 8/12 41 1656
50 7/26 21 482
120 7/31 - 13 481
200 8/7 16 1332
150 8/2 16 872
150 8/9 16 809
190 8/5 22 1073
140 8/5 17 1015
200 8/5 16 1300
175 7/31 13 770
200 8/9 14 980
130 8/5 12 570
144.5 18.8 859.3
Discussion
In the 22 cases studied, the eosinophils prior to starting the
histamine injections averaged 3.44 per cent and at the end of the
course of injections averaged 3.70 per cent. It is apparent that in
this series of patients histamine exerted no appreciable effect on the
level ofbloodeosinophils. This wasconfirmedby an analysis which
showed that the difference in the two averages is not statistically
significant. Although the number of patients studied is small, the816 YALE JOURNAL OF BIOLOGY AND MEDICINE
results are sufficiently definite to claim that injections of histamine
given over a period of many weeks do not consistently cause an
appreciable change in the percentage of circulating eosinophils.
Since there seems to be some interrelationship between allergic con-
ditions, histamine, and blood eosinophils, as mentioned earlier, a
definite change in the eosinophil percentage under the conditions of
the experiment might have been of some theoretical interest. Since
there was no significant change, it would appear that the therapeutic
value of histamine injections in allergic diseases is not the result of
a change in the percentage of circulating eosinophils.
Summary
Twenty-two patients subject to hay-fever received a long series
of histamine injections without producing a significant change in the
average level of circulating eosinophils.
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